IFN-γ- and cell-to-cell contact-dependent cytotoxicity of allograft- induced macrophages against syngeneic tumor cells and cell lines: An application of allografting to cancer treatment

Journal of Immunology

Volumn 163, Issue 1, 1999, Pages 148-154

  Yoshida, Ryotaro ^a   Yoneda, Yukio ^b   Kuriyama, Manabu ^c   Kubota, Takahiro ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Shiga 525 0055   (Japan)

^c GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GAMMA INTERFERON;

ALLOGENEIC RESTRICTION; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CELL CONTACT; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; GRANULOCYTE; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TRANSPLANTATION; TUMOR CELL LINE;

3T3 CELLS; ANIMALS; CELL COMMUNICATION; CELL DIVISION; CYTOTOXICITY, IMMUNOLOGIC; FIBROBLASTS; GRAFT REJECTION; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE II; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; SARCOMA, EXPERIMENTAL; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; TUMOR CELLS, CULTURED;

EID: 0033168138     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fidler, I. J., and I. R. Hart. 1982. Biological diversity in metastatic neoplasms: origin and implications. Science 217:998.
2. Fidler, I. J., and G. Poste. 1982. Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease. Semin. Immunopathol. 5:161.
3. Rollins, B. J., and M. E. Sunday. 1991. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell. Biol. 11:3125.
4. Mantovani, A., B. Bottazzi, F. Colotta, F. Sozzini, and L. Ruco. 1992. The origin and function of tumor-associated macrophages. Immunol. Today 13:265.
5. Van Netten, J. P., E. J. Geodge, B. J. Ashmead, C. Fletcher, I. G. Thornton, and P. Coy. 1993. Macrophage-tumor cell associations in breast cancer. Lancet 342:372.
6. Mintz, B., and W. K. Silvers. 1967. "Intrinsic" immunological tolerance in allophenic mice. Science 158:1484.
7. -1- mice. J. Immunol. 159:1418.
8. Yoneda, Y., and R. Yoshida. 1998. The role of T cells in allografted tumor rejection: IFN-γ released from T cells is essential for induction of effector macrophages in the rejection site. J. Immunol. 160:6012.
9. Yoshida, R., O. Takikawa, T. Oku, and A. Habara-Ohkubo. 1991. Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice. Proc. Natl. Acad. Sci. USA 88:1526.
10. Yoshida, R., A. Matsuura, K. Einaga, Y. Ushio, N. Yamamoto, and Y. Yoneda. 1996. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection site: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens. Microbiol. Immunol. 41:149.
11. Ushio, Y., N. Yamamoto, A. Sanchez-Bueno, and R. Yoshida. 1996. Failure to reject an allografted tumor after elimination of macrophages in mice. Microbiol. Immunol. 40:489.
12. Takikawa, O., T. Oku, N. Ito, Y. Ushio, N. Yamamoto, Y. Yoneda, J. Tsuji, A. Sanchez-Bueno, V. Verkhusha, and R. Yoshida. 1996. Multiple expression of Ly-6C and accumulation of a Ly-6C pre-mRNA in activated macrophages involved in rejection of an allografted tumor. Biochem. Biophys. Res. Commun. 226:247.
13. Yoshida, R., S. W. Park, H. Yasui, and O. Takikawa. 1988. Tryptophan degradation in transplanted tumor cells undergoing rejection. J. Immunol. 141:2819.
14. Takikawa, O., A. Habara-Ohkubo, and R. Yoshida. 1990. IFN-γ is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. J. Immunol. 145:1246.
15. Takikawa, O., T. Oku., H. Yasui, and R. Yoshida. 1993. Synergism between IFN-γ and IL-1α/β in growth inhibition of an allografted tumor. J. Immunol. 151:2070.
16. 2+-dependent, Fas- and perforin- independent apoptotic death of allografted tumor cells by a type of activated macrophage. J. Immunol. 159:15.
17. Sanchez-Bueno, A., V. Verkhusha, Y. Tanaka, O. Takikawa, and R. Yoshida. 1996. Interferon-γ-dependent expression of inducible nitric oxide synthase, interleukin-12, and interferon-γ-inducing factor in macrophages elicited by allografted tumor cells. Biochem. Biophys. Res. Commun. 224:555.
18. Ushio-Umeda, Y., and R. Yoshida. 1997. Mechanisms of allografted tumor rejection: the roles of T cells in allograft rejection mediated by a type of bone marrow-derived macrophage. Microbiol. Immunol. 41:981.
19. Yamamoto, N., K. Einaga-Naito, M. Kuriyama, Y. Kanada, and R. Yoshida. 1998. Cellular basis of skin allograft rejection in mice: Specific lysis of allogeneic skin components by non-T cells. Transplantation 65:818.
20. Hansel, T. T., J. D. Pound, D. Pilling, G. D. Kitas, M. Salmon, T. A. Gentle, S. S. Lee, and R. A. Thompson. 1989. Purification of human blood eosinophils by negative selection using immunomagnetic beads. J. Immunol. Methods 122:97.
21. Ascher, N., R. M. Ferguson, R. Hoffman, and R. L. Simmons. 1979. Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation 27:254.
22. Winn, H. J. 1961. Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J. Immunol. 86:228.
23. Green, M. I., S. Fujimoto, and A. H. Sehon. 1977. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing host. J. Immunol. 119:757.
24. Fidler, I. J. 1985. Macrophages and metastasis: a biologic approach to cancer therapy. Cancer Res. 45:4714.
25. Hume, D. A., R. E. Donahue, and I. J. Fidler. 1989. The therapeutic effect of human recombinant macrophage colony stimulating factor (CSF-1) in experimental murine metastatic melanoma. Lymphokine Res. 8:69.
26. Hayashi, A. 1994. Interferon-γ as a marker for the effective cancer immunotherapy with BCG-cell wall skeleton. Proc. Jpn. Acad. Ser B 70:205.
27. Lechler, R. I., G. Lombardi, J. R. Bachelor, N. Reinsmoen, and F. H. Bach. 1990. The molecular basis of alloreactivity. Immunol. Today 11:83.
28. 2-microglobulin-deficient mice. J. Exp. Med. 175:885.
29. -1- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J. Immunol. 156:4114.
30. + T cell populations. Transplantation 62:300.
31. + cells are essential for allorejection. J. Exp. Med. 184:2013.
32. Martin, P. J., J. A. Hansen, R. Storb, and E. D. Thomas. 1987. Human marrow transplantation: an immunological perspective. Adv. Immunol. 40:379.
33. Weiden, P. L., N. Flournoy, D. Thomas, R. Prentice, A. Fefer, D. Buckner, and R. Storb. 1979. Antileukemic effect of graft- versus-host disease in human recipients of allogeneic- marrow grafts. N. Engl. J. Med.300:1068.
34. Bacigalupo, A., M. T. Van Lint, F. Frassoni, and A. Marmont. 1985. Graftversus-leukemia effect following allogeneic bone marrow transplantation. Br. J. Haematol. 61:749.
35. Thomas, E. D., C. D. Buckner, M. Banaji, R. A. Clift, A. Fefer, N. Floumoy, B. W. Goodell, R. O. Hickman, K. G. Lerner, P. E. Neiman, et al. 1977. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49:511.
36. Champlin, R., J. Jansen, W. Ho, J. Gajewski, S. Nimer, K. Lee, M. Territo, D. Winston, G. Tricot, and T. Reichert. 1991. Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia. Transplant. Proc. 23:1695.